Peer review as a quality assurance mechanism in three pharmacist-run medication-refill clinics

Autor: D Sugiyama, M Stebbins, N Ratto, HS Eom, Cram Dl

Publikováno v: American Journal of Health-System Pharmacy. 49:2727-2730

A peer-review system for monitoring pharmacists' practice in medication-refill clinics is described. Pharmacist practitioners trained in pharmacology, therapeutics, and physical assessment provide services in three medication-refill clinics associate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34169f62185c66f7a031835838d95d5b
https://doi.org/10.1093/ajhp/49.11.2727

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study.

Autor: Lee JH; Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan., Choi J; Department of Management information system, College of Business Administration, Dong-A University, Busan., Min CK; Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul., Park SS; Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul., Jo JC; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan., Lee YJ; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan., Kim JS; Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul., Eom HS; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang., Jung J; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang., Moon JH; Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu., Cho HJ; Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu., Lee MW; Division of Hematology and Oncology,Department of Internal Medicine, Chungnam National University Hospital, Daejeon., Yoon SS; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul., Byun JM; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul., Lee JH; Gachon University Medical College, Division of Hematology, Gachon University Gil Medical Center, Incheon., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Jeollanam-do., Jung SH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Jeollanam-do., Shin HJ; Division of Hematology-oncology, Department of Internal Medicine, Pusan National University Hospital, Busan., Kim DY; Division of Hematology-oncology, Department of Internal Medicine, Pusan National University Hospital, Busan., Yi JH; Division of Hematology-Oncology, Department of Medicine, Chung-Ang University, Seoul., Lee SS; Department of Hematology-Oncology, Wonkwang University Hospital, Iksan., Do YR; Department of Hemato-Oncology, Keimyung University, Dongsan Medical Center, Daegu., Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul., Cho H; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul., Lee WS; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan., Lee HS; Department of Internal Medicine, Kosin University College of Medicine, Busan., Uhm J; Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul., Kim HJ; Department of Hematology-Oncology, Hallym University Medical Center, Hallym University College of Medicine, Anyang., Jang HR; Kangwon National University Hospital, Division of Hematology, Chuncheon, Gangwon-do, South Korea; and., Kim SH; Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan. kshmoon@dau.ac.kr., Kim K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul.

Publikováno v: Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3681-3692. Date of Electronic Publication: 2024 Nov 01.

Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era.

Autor: Choi WJ; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea., Lee J; Infection Control Unit, National Cancer Center, Goyang, Republic of Korea., Choi K; Infection Control Unit, National Cancer Center, Goyang, Republic of Korea., Kim DM; Infection Control Unit, National Cancer Center, Goyang, Republic of Korea., Han N; Department of Pathology, National Cancer Center Hospital, National Cancer Center, Goyang, Republic of Korea., Choi JH; Department of Thoracic Surgery, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Jung J; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea., Lee H; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea., Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Choi YJ; Division of Infectious Disease, Department of Internal Medicine, National Cancer Center, Goyang, Republic of Korea., Eom HS; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea., Chun JY; Division of Infectious Disease, Department of Internal Medicine, National Cancer Center, Goyang, Republic of Korea., Lee E; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea. Electronic address: eunyounglee@ncc.re.kr.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Oct; Vol. 147, pp. 107207. Date of Electronic Publication: 2024 Aug 13.

Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.

Autor: Rai S; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka-Sayama. rai@med.kindai.ac.jp., Kim WS; Division of Hematology Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul., Ando K; Hematology and Oncology, Tokai University Hospital, Isehara., Choi I; Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka., Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo., Tsukamoto N; Oncology Center, Gunma University Hospital, Maebashi., Maruyama D; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo., Tsukasaki K; Hematology, International Medical Center, Saitama Medical University, Saitama., Kuroda J; Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto., Ando J; Department of Hematology, Juntendo University School of Medicine, Tokyo., Hidaka M; Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto., Koh Y; Internal Medicine, Seoul National University Hospital, Seoul., Kato H; Hematology and Oncology, Osaka University Graduate School of Medicine, Suita., Uchida T; Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya., Yang DH; Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National Medical School, Gwangju., Ishitsuka K; Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima., Ishizawa K; Third Internal Medicine, Yamagata University Hospital, Yamagata., Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul., Lee HG; Hematology and Oncology, Konkuk University Medical Center, Seoul., Minami H; Medical Oncology/Hematology, Kobe University Hospital, Kobe., Eom HS; Center for Hematologic Malignancy, National Cancer Center, Goyang-si., Kurosawa M; Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo., Lee JH; Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon., Lee JS; Division of Hematology-Oncology, Seoul National University Bundang Hospital, Gyeonggi., Lee WS; Internal Medicine, Inje University Busan Paik Hospital, Busan., Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya., Shindo T; Hematology and Oncology, Kyoto University Hospital, Kyoto., Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul., Yoshida S; Hematology, National Hospital Organization Nagasaki Medical Center, Omura., Gillings M; HUYABIO International, San Diego, CA., Onogi H; Huya Japan GK, Tokyo., Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo.

Publikováno v: Haematologica [Haematologica] 2024 Oct 01; Vol. 109 (10), pp. 3357-3362. Date of Electronic Publication: 2024 Oct 01.

Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.

Autor: Yi JH; Division of Hematology-Oncology, Department of Medicine, Chung-Ang University, Seoul, Korea., Park SS; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, Catholic University, Seoul, Korea., Min CK; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, Catholic University, Seoul, Korea., Eom HS; Department of Internal Medicine, National Cancer Center, Goyang, Korea., Byun JM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Lee JH; Department of Hematology, Gachon University College of Medicine, Incheon, Korea., Jung SH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Hwasun-gun, Jeollanam-do, Korea., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Hwasun-gun, Jeollanam-do, Korea., Yoon SE; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 06351, Korea., Woo SY; Biomedical Statistics Center, Data Science Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea., Kim K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 06351, Korea. kihyunkimk@gmail.com.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2365-2372. Date of Electronic Publication: 2024 Jan 25.